Scientists at Joslin Diabetes Center now have created the first iPSCs that offer a human model of insulin resistance, a key driver of type 2 diabetes.
24-Jul-2014 1:00 PM EDT
– Edward Horton, M.D., Senior Investigator at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, received the Master of the American College of Endocrinology (MACE) Award at the American Association of Clinical...
14-Jul-2014 10:00 AM EDT
When a pregnant mother is undernourished, her child is at a greater than average risk of developing obesity and type 2 diabetes, in part due to so-called ‘epigenetic’ effects.
10-Jul-2014 2:30 PM EDT
Building upon their earlier research on the biology of fat metabolism, Joslin scientists discovered that microRNAs –small RNA molecules that play important roles in regulation in many types of tissue – play a major role in the distribution and...
1-Jul-2014 5:00 PM EDT
Joslin Diabetes Center and Carlos Slim Health Institute Announce Collaboration to Develop Online Educational Materials for General Practitioners in Mexico
Joslin Diabetes Center and Carlos Slim Health Institute (CSHI) announced they have created a partnership to develop a series of online “virtual” case based interactive educational materials for primary care physicians in Mexico.
16-Jun-2014 11:00 AM EDT
Joslin and Steno Establish Partnership to Improve Clinical Outcomes and to Strengthen Education in Developing Countries
Joslin Diabetes Center and Steno Diabetes Center today announced a long-term partnership to improve clinical outcomes in diabetes care.
13-Jun-2014 1:00 PM EDT
The results of a 20-year study confirm that people with Type 1 diabetes who have developed kidney complications can slow the progress of their complications by improving control of their blood glucose over the long term. This finding may lead to...
5-Jun-2014 2:55 PM EDT
Joslin Diabetes Center announced today that Lori Laffel, M.D., M.P.H., Chief of the Pediatric, Adolescent and Young Adult Section at Joslin and Associate Professor of Pediatrics at Harvard Medical School, and Howard Wolpert, M.D., Director of the...
13-May-2014 11:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT